查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1593858

活細胞封裝市場：依技術、聚合物、應用分類 - 2025-2030 年全球預測

Live Cell Encapsulation Market by Techniques (Coaxial Airflow, Electrostatic Dripping, Jet Cutting), Polymer (2-Hydroxyethyl Methacrylate & Methyl Methacrylate, Alginate, Cellulose Sulfate), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年活細胞封裝市場價值為3.1229億美元，預計到2024年將達到3.2589億美元，複合年成長率為4.44%，預計到2030年將達到4.2354億美元。

活細胞封裝是一種生物醫學技術，將活細胞封裝在半透膜或膠囊中，允許分子交換，同時保護它們免受宿主免疫系統的影響。該技術具有多種醫療應用的潛力，包括細胞療法、再生醫學和藥物傳輸系統。其主要需求源自於其為移植細胞提供免疫保護的能力，這對於治療糖尿病、癌症、神經退化性疾病等至關重要。其應用範圍廣泛，包括研究和治療實踐，其中封裝細胞用於釋放治療劑、細胞替代療法和創建生物人工器官。最終用途部分主要包括專注於先進治療方法的醫院、研究機構和製藥公司。

主要市場統計
基準年[2023] 31229萬美元
預測年份 [2024] 32589萬美元
預測年份 [2030] 42354萬美元
複合年成長率（%） 4.44%

推動市場成長的關鍵因素包括生物技術和醫療保健的投資增加、生物材料和生物相容性的進步以及需要創新治療方法的慢性疾病的盛行率上升。同時，意識的提高和醫療保健支出的增加正在推動進一步的需求。然而，生物相容性、擴充性和監管障礙等挑戰是主要限制。市場開拓公司必須克服高昂的研發成本和維持膠囊內細胞活力的複雜性。

潛在的商機在於開發更複雜的生物材料和封裝技術、個人化醫療以及將實驗室進展轉化為臨床實踐的產學合作。人們對活細胞封裝在食品和食品領域的潛力也越來越感興趣。公司應專注於奈米封裝和生物分解性聚合物等創新領域。研究表明，在持續研究和對先進治療的需求不斷成長的推動下，市場正趨於中高速成長。策略夥伴關係和強力的監管策略對於克服現有挑戰至關重要。市場是充滿活力的，主要由技術進步和對創新治療方法的明確需求推動，創造了一個充滿希望但競爭激烈的格局。

市場動態：快速發展的活細胞封裝市場的關鍵市場洞察

供需的動態交互作用正在改變活細胞封裝市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 白喉、破傷風、小兒麻痺、脊髓灰質炎、結核病等目標疾病發生率上升。
    • 透過公共和私人投資來支持新產品開發和技術進步
    • 社會對封裝細胞在疾病管理中臨床作用的認知
  • 市場限制因素
    • 生產成本高
  • 市場機會
    • 關注新的藥物輸送系統
    • 正在進行的活細胞封裝開發研究活動
  • 市場挑戰
    • 替代療法的可用性和採用

波特五力：駕馭活細胞封裝市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解活細胞封裝市場的外部影響

外部宏觀環境因素在塑造活細胞封裝市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解活細胞封裝市場的競爭格局

對活細胞封裝市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣活細胞封裝市場供應商績效評估

FPNV定位矩陣是評估活細胞封裝市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了活細胞封裝市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對活細胞封裝市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 白喉、破傷風、小兒麻痺、脊髓灰質炎和結核病等目標疾病的發生率增加。
      • 透過公共和私人投資支持新產品開發與技術創新相結合的投資
      • 大眾對封裝細胞在疾病管理中臨床作用的認知
    • 抑制因素
      • 生產成本高
    • 機會
      • 專注於新型藥物輸送系統
      • 正在進行的活細胞封裝開發研究活動
    • 任務
      • 替代療法的可用性和採用
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章活細胞封裝市場技術

  • 同軸氣流
  • 由於靜電而滴落
  • 噴射切割
  • 液體噴射拆卸
  • 旋轉盤噴霧
  • 簡單的滴水
  • 振動噴射技術

第7章活細胞封裝市場聚合物

  • 甲基丙烯酸2-羥乙酯和甲基丙烯酸甲酯
  • 海藻酸
  • 硫酸纖維素
  • 幾丁聚醣
  • PAN-PVC
  • 矽質膠囊

第8章活細胞封裝市場：依應用

  • 細胞移植
  • 藥物輸送
  • 益生菌
  • 再生醫學
  • 調查

第9章北美和南美活細胞封裝市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太活細胞封裝市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲活細胞封裝市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Austrianova Singapore Pte Ltd
  • Beta-O2 Technologies Ltd.
  • Biotime, Inc.
  • Blacktrace Holdings Ltd.
  • BUCHI Labortechnik AG
  • Defymed SAS
  • Evonik Industries AG
  • Kadimastem
  • Living Cell Technologies Limited.
  • Merck KGaA
  • Neurotech Holdings, LLC.
  • Pharmacyte Biotech, Inc.
  • Reed Pacific Pty Limited
  • Sernova Corporation
  • Sigilon Therapeutics, Inc.
  • Viacyte, Inc.
Product Code: MRR-437517DB6D5D

The Live Cell Encapsulation Market was valued at USD 312.29 million in 2023, expected to reach USD 325.89 million in 2024, and is projected to grow at a CAGR of 4.44%, to USD 423.54 million by 2030.

Live cell encapsulation is a biomedical technology where live cells are enclosed within semi-permeable membranes or capsules, protecting them from the host's immune system while allowing the exchange of molecules. This technique holds potential in various medical applications such as cell therapy, regenerative medicine, and drug delivery systems. Its primary necessity stems from its ability to provide immune protection to transplanted cells, which is crucial for treating conditions like diabetes, cancer, and neurodegenerative diseases. The application scope is broad, involving research and therapeutic practice, where encapsulated cells can be used to release therapeutic agents, offer cell replacement therapy, and create bioartificial organs. End-use segments primarily include hospitals, research institutes, and pharmaceutical companies focusing on advanced therapeutic methods.

KEY MARKET STATISTICS
Base Year [2023] USD 312.29 million
Estimated Year [2024] USD 325.89 million
Forecast Year [2030] USD 423.54 million
CAGR (%) 4.44%

Key factors driving market growth include increasing investments in biotechnology and healthcare, advancements in biomaterials and biocompatibility, and the rising prevalence of chronic diseases requiring innovative treatment modalities. Simultaneously, growing awareness and healthcare expenditure are spurring further demand. However, challenges such as biological compatibility, scalability, and regulatory hurdles pose significant limitations. Market players must navigate high research and development costs and the complexity of maintaining cell viability within capsules.

Potential opportunities lie in developing more sophisticated biomaterials and encapsulation techniques, personalized medicine, and collaborations between industry and academia to translate laboratory advancements into clinical settings. There's also a growing interest in the potential of live cell encapsulation in food and nutraceutical sectors. Businesses should focus on areas of innovation like nanoencapsulation and biodegradable polymers. Insights suggest a market leaning towards moderate to high-growth trends, driven by continuous research and the burgeoning demand for advanced therapies. Strategic partnerships and robust regulatory strategies will be critical for overcoming existing challenges. The market is dynamic, primarily propelled by technological advances and a clear demand for innovative treatment methods, ensuring a promising yet competitive landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Live Cell Encapsulation Market

The Live Cell Encapsulation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidences of target diseases including target diseases, diphtheria, tetanus, poliomyelitis, measles, and tuberculosis
    • Investment via public-private investments to support the novel product development coupled with technology advancements
    • Public awareness related to the clinical role of encapsulated cells in disease management
  • Market Restraints
    • High production cost
  • Market Opportunities
    • Focus on Novel drug delivery systems
    • Ongoing research activities for development of live cell encapsulation
  • Market Challenges
    • Availability and adoption of alternative therapies

Porter's Five Forces: A Strategic Tool for Navigating the Live Cell Encapsulation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Live Cell Encapsulation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Live Cell Encapsulation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Live Cell Encapsulation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Live Cell Encapsulation Market

A detailed market share analysis in the Live Cell Encapsulation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Live Cell Encapsulation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Live Cell Encapsulation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Live Cell Encapsulation Market

A strategic analysis of the Live Cell Encapsulation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Live Cell Encapsulation Market, highlighting leading vendors and their innovative profiles. These include Austrianova Singapore Pte Ltd, Beta-O2 Technologies Ltd., Biotime, Inc., Blacktrace Holdings Ltd., BUCHI Labortechnik AG, Defymed SAS, Evonik Industries AG, Kadimastem, Living Cell Technologies Limited., Merck KGaA, Neurotech Holdings, LLC., Pharmacyte Biotech, Inc., Reed Pacific Pty Limited, Sernova Corporation, Sigilon Therapeutics, Inc., and Viacyte, Inc..

Market Segmentation & Coverage

This research report categorizes the Live Cell Encapsulation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Techniques, market is studied across Coaxial Airflow, Electrostatic Dripping, Jet Cutting, Liquid-Jet Break-Up, Rotating Disk Atomization, Simple Dripping, and Vibrating-Jet Technique.
  • Based on Polymer, market is studied across 2-Hydroxyethyl Methacrylate & Methyl Methacrylate, Alginate, Cellulose Sulfate, Chitosan, PAN-PVC, and Siliceous Encapsulates.
  • Based on Application, market is studied across Cell Transplantation, Drug Delivery, Probiotics, Regenerative Medicine, and Research.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of target diseases including target diseases, diphtheria, tetanus, poliomyelitis, measles, and tuberculosis
      • 5.1.1.2. Investment via public-private investments to support the novel product development coupled with technology advancements
      • 5.1.1.3. Public awareness related to the clinical role of encapsulated cells in disease management
    • 5.1.2. Restraints
      • 5.1.2.1. High production cost
    • 5.1.3. Opportunities
      • 5.1.3.1. Focus on Novel drug delivery systems
      • 5.1.3.2. Ongoing research activities for development of live cell encapsulation
    • 5.1.4. Challenges
      • 5.1.4.1. Availability and adoption of alternative therapies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Live Cell Encapsulation Market, by Techniques

  • 6.1. Introduction
  • 6.2. Coaxial Airflow
  • 6.3. Electrostatic Dripping
  • 6.4. Jet Cutting
  • 6.5. Liquid-Jet Break-Up
  • 6.6. Rotating Disk Atomization
  • 6.7. Simple Dripping
  • 6.8. Vibrating-Jet Technique

7. Live Cell Encapsulation Market, by Polymer

  • 7.1. Introduction
  • 7.2. 2-Hydroxyethyl Methacrylate & Methyl Methacrylate
  • 7.3. Alginate
  • 7.4. Cellulose Sulfate
  • 7.5. Chitosan
  • 7.6. PAN-PVC
  • 7.7. Siliceous Encapsulates

8. Live Cell Encapsulation Market, by Application

  • 8.1. Introduction
  • 8.2. Cell Transplantation
  • 8.3. Drug Delivery
  • 8.4. Probiotics
  • 8.5. Regenerative Medicine
  • 8.6. Research

9. Americas Live Cell Encapsulation Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Live Cell Encapsulation Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Live Cell Encapsulation Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Austrianova Singapore Pte Ltd
  • 2. Beta-O2 Technologies Ltd.
  • 3. Biotime, Inc.
  • 4. Blacktrace Holdings Ltd.
  • 5. BUCHI Labortechnik AG
  • 6. Defymed SAS
  • 7. Evonik Industries AG
  • 8. Kadimastem
  • 9. Living Cell Technologies Limited.
  • 10. Merck KGaA
  • 11. Neurotech Holdings, LLC.
  • 12. Pharmacyte Biotech, Inc.
  • 13. Reed Pacific Pty Limited
  • 14. Sernova Corporation
  • 15. Sigilon Therapeutics, Inc.
  • 16. Viacyte, Inc.

LIST OF FIGURES

  • FIGURE 1. LIVE CELL ENCAPSULATION MARKET RESEARCH PROCESS
  • FIGURE 2. LIVE CELL ENCAPSULATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES LIVE CELL ENCAPSULATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES LIVE CELL ENCAPSULATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. LIVE CELL ENCAPSULATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. LIVE CELL ENCAPSULATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. LIVE CELL ENCAPSULATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. LIVE CELL ENCAPSULATION MARKET DYNAMICS
  • TABLE 7. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY COAXIAL AIRFLOW, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY ELECTROSTATIC DRIPPING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY JET CUTTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY LIQUID-JET BREAK-UP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY ROTATING DISK ATOMIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY SIMPLE DRIPPING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY VIBRATING-JET TECHNIQUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY 2-HYDROXYETHYL METHACRYLATE & METHYL METHACRYLATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY ALGINATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY CELLULOSE SULFATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY CHITOSAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY PAN-PVC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY SILICEOUS ENCAPSULATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY CELL TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES LIVE CELL ENCAPSULATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. JAPAN LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 65. JAPAN LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. MALAYSIA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 68. MALAYSIA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 69. MALAYSIA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. PHILIPPINES LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 71. PHILIPPINES LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 72. PHILIPPINES LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. SINGAPORE LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 74. SINGAPORE LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 75. SINGAPORE LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. SOUTH KOREA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 77. SOUTH KOREA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 78. SOUTH KOREA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. TAIWAN LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 80. TAIWAN LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 81. TAIWAN LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. THAILAND LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 83. THAILAND LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 84. THAILAND LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. VIETNAM LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 86. VIETNAM LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 87. VIETNAM LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 92. DENMARK LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 93. DENMARK LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 94. DENMARK LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. EGYPT LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 96. EGYPT LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 97. EGYPT LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. FINLAND LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 99. FINLAND LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 100. FINLAND LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. FRANCE LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 102. FRANCE LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 103. FRANCE LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. GERMANY LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 105. GERMANY LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 106. GERMANY LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. ISRAEL LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 108. ISRAEL LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 109. ISRAEL LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. ITALY LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 111. ITALY LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 112. ITALY LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NETHERLANDS LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 114. NETHERLANDS LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 115. NETHERLANDS LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. NIGERIA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 117. NIGERIA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 118. NIGERIA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. NORWAY LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 120. NORWAY LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 121. NORWAY LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. POLAND LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 123. POLAND LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 124. POLAND LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. QATAR LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 126. QATAR LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 127. QATAR LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. RUSSIA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 129. RUSSIA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 130. RUSSIA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SAUDI ARABIA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 132. SAUDI ARABIA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 133. SAUDI ARABIA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH AFRICA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH AFRICA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 136. SOUTH AFRICA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SPAIN LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 138. SPAIN LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 139. SPAIN LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. SWEDEN LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 141. SWEDEN LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 142. SWEDEN LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. SWITZERLAND LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 144. SWITZERLAND LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 145. SWITZERLAND LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. TURKEY LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 147. TURKEY LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 148. TURKEY LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED ARAB EMIRATES LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED ARAB EMIRATES LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED ARAB EMIRATES LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. UNITED KINGDOM LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 153. UNITED KINGDOM LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 154. UNITED KINGDOM LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. LIVE CELL ENCAPSULATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 156. LIVE CELL ENCAPSULATION MARKET, FPNV POSITIONING MATRIX, 2023